Efficacy and Safety of Imprime Pgg, a Novel Innate Immune Modulator, in Combination with Bevacizumab (BEV), Carboplatin and Paclitaxel for the 1St-Line Treatment of Stage Iv Nsclc
Titel:
Efficacy and Safety of Imprime Pgg, a Novel Innate Immune Modulator, in Combination with Bevacizumab (BEV), Carboplatin and Paclitaxel for the 1St-Line Treatment of Stage Iv Nsclc
Auteur:
Braun, A. Engel-Riedel, W. Schneller, F. Wolf, M. Schuette, W. Lowe, J. Mattson, P. Gargano, M. Patchen, M. Huhn, R.